权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The role of the mitochondrial protein dimer CHCHD2/10 in health and disease

线粒体蛋白二聚体 CHCHD2/10 在健康和疾病中的作用

基本信息

批准号：
9807027
负责人：
Giovanni Manfredi
金额：
$ 42.55万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-06-15 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9807027
关键词：
1 year old Address Affect Amino Acid Substitution Area Behavioral Biochemical Biological Markers Body Weight decreased Brain Cardiomyopathies Cells Chronic Complex Crista ampullaris Development Disease Disease Progression Electron Microscopy FRAP1 gene Family Frontotemporal Dementia Genetic Genetic Diseases Genetic Transcription Goals Health Heart Heart Mitochondria Human Inner mitochondrial membrane Knock-in Mouse Knockout Mice Knowledge Link Longevity Mediating Metabolic Metabolism Mitochondria Mitochondrial Diseases Mitochondrial Matrix Mitochondrial Proteins Molecular Molecular Biology Molecular Weight Monitor Morphologic artifacts Morphology Motor Motor Neuron Disease Motor Neurons Mus Muscle Muscle Mitochondria Mutant Strains Mice Mutation Myopathy Names Nerve Degeneration Nervous system structure Neurodegenerative Disorders Neuromuscular Diseases Neuromuscular Junction Organ Organelles Pathogenesis Pathogenicity Pathologic Pathology Pathway interactions Patients Pharmacology Phenotype Plasma Proteins Proteomics Reporting Role Signal Transduction Sirolimus Skeletal Muscle Spinal Stress Swelling System Systemic disease Testing Therapeutic Tissues Transgenic Organisms Vacuole Work biological adaptation to stress dimer disease phenotype dopaminergic neuron improved in vivo loss of function metabolome metabolomics mitochondrial dysfunction molecular marker motor deficit mouse model muscle form mutant novel overexpression paralogous gene premature promoter protein function proteotoxicity response biomarker stress granule therapeutic evaluation transcriptomics

项目摘要

Skeletal muscle, heart, and brain are high-energy requiring tissues that are severely affected by mitochondrial dysfunction. Recently a novel form of genetic disease affecting mitochondria has been associated with mutations in a mitochondrial protein, CHCHD10 (D10), whose function is still largely unknown. Mutant D10 causes severe autosomal dominant mitochondrial diseases, with diverse phenotypic features, ranging from myopathy to motor neuron disease and frontotemporal dementia. We previously showed that in mitochondria D10 forms a dimeric complex with its paralog protein, CHCHD2 (D2). Interestingly, mutations in D2 are also associated with familial neurodegenerative diseases. To study the manifestations and disease mechanisms of mutant D10 in vivo, we have generated a knock in mouse harboring the first pathogenic D10 mutation reported in humans (S59L, corresponding to mouse S55L). In D10S55L mouse muscle and heart mitochondria, D10 and D2 accumulate and aggregate, leading to mitochondrial dysfunction and degeneration. These abnormalities result in a profound integrated mitochondrial stress response (ISRmt), altering transcriptional profiles and metabolism, and ultimately resulting in fatal cardiomyopathy. Conversely, D10 knock out mice do not manifest mtISR and are phenotypically normal, suggesting that D10S55L causes disease through a toxic mechanism and not a loss of function. In this application, we will study the normal function of D10 and D2 and the mechanisms underlying mitochondrial alterations in D10S55L mice. Since D10 mutations cause neurodegeneration in humans, we will also investigate the involvement of the nervous system in D10S55L mice. We will then identify metabolic and molecular biomarkers to help monitor disease course. Lastly, we will test the effects of pharmacological modulation of ISRmt in D10S55L mice as a therapeutic strategy. The impact of this project will be to facilitate rationale approaches to target disease pathogenesis in patients with D10 mutations, which could be extended to other mitochondrial diseases mediated by ISRmt

骨骼肌、心脏和大脑是需要高能量的组织，受到严重的线粒体功能障碍。最近，一种影响线粒体的新形式的遗传病与线粒体蛋白CHCHD10(D10)的突变有关，其功能是这在很大程度上仍然是未知的。突变D10导致严重的常染色体显性遗传性线粒体疾病，有不同的表型特征，从肌病到运动神经元疾病和额颞部痴呆。我们之前发现，在线粒体中，D10以二聚体的形式存在与其伴生蛋白CHCHD2(D2)的复合体。有趣的是，D2基因的突变也与患有家族性神经退行性疾病。研究其临床表现和发病机制体内突变的D10，我们已经在携带第一个致病D10的小鼠中产生了敲击在人类中发现的突变(S59L，对应于小鼠的S55L)。在D10S55L小鼠肌肉中而心脏线粒体、D10和D2积累和聚集，导致线粒体功能障碍和退化。这些异常导致了线粒体的深度整合。应激反应(ISRmt)，改变转录谱和新陈代谢，最终导致死于致命的心肌病。相反，D10基因敲除小鼠不会表现出mtISR，而是表型正常，提示D10S55L通过毒性机制和而不是丧失功能。在这个应用中，我们将研究D10和D2的正规函数以及 D10S55L小鼠线粒体改变的机制。因为D10突变会导致，我们还将研究神经系统在 D10S55L小鼠。然后我们将确定代谢和分子生物标记物，以帮助监测疾病当然了。最后，我们将检测ISRmt对D10S55L小鼠AS的药理调节作用。一种治疗策略。该项目的影响将是促进合理的方法来实现目标 D10突变患者的疾病发病机制，这可能扩展到其他 ISRmt介导的线粒体疾病